Reduction of antineoplastic drug intoxication by 5-hydroxytryptamine antagonists.
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity; D003630:Daunorubicin / Q000494:pharmacology / Q000633:toxicity*; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D008466:Mechlorethamine / Q000494:pharmacology / Q000633:toxicity*; D008784:Methysergide / Q000494:pharmacology; D051379:Mice; D009026:Mortality; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists
D000970:Antineoplastic Agents; D004873:Ergolines; D012702:Serotonin Antagonists; D012701:Serotonin; D008466:Mechlorethamine; D008784:Methysergide; D003630:Daunorubicin